Comparative Clinical Evaluation of Sahachara Taila Nasya and Matra Basti in Vishwachi(Cervical Radiculopathy)
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- No improvement: 0-25%
研究概览
简要总结
Cervical radiculopathy arises from degenerative changes in the cervical spine. It commonly emerges during the fourth and fifth decades of life. Lifestyle factors, such as prolonged screen use, sedentary habits, and occupational strain, significantly contribute to its widespread occurrence. This ailment disrupts daily life, causing neck pain, radiating discomfort, and sensory disturbances. The contemporary surge in cervical radiculopathy highlights the impact of evolving lifestyles on musculoskeletal health, underscoring the need for proactive preventive measures. The Sushruta Samhita Nidana Sthana classifies Vishwachi under Vata Vikara, affecting the neck and upper extremities with symptoms akin to cervical radiculopathy. Both conditions share manifestations of Ruka, Stambha, Toda, Karmakshaya, and Chestapaharan of Bahu with Vata being the predominant Dosha responsible for Shoola. Due to the Snighdha Guna and Ushna Veerya of Sahachara Taila, It has Vata-Kapha Shamaka, Vednasthapana and Shothahara properties. In this study, we are comparing the effect of Sahachara Tail Matra Basti and Sahachara Tail Nasya in patients with classical symptoms of Vishwachi and fulfilling the diagnostic criteria of cervical radiculopathy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients irrespective of gender between the age group of 20 to 50 yrs.
- •Patient diagnosed with cervical radiculopathy according to assessment criteria (neck disability index).
- •Patients fit for Nasya Karma and Matra Basti.
排除标准
- •Severe hypertension and uncontrolled diabetes mellitus.
- •Known case of acute or chronic infection of the spine.
- •Paralyzed and traumatic causes like injury, accidents etc.
- •Known case of malignancy.
- •Any other form of arthritis like rheumatoid arthritis etc.
- •Pregnant and lactating women.
结局指标
主要结局
No improvement: 0-25%
时间窗: 1st day, 11th day, 21st day, 31st day
Mild improvement: 26-50%
时间窗: 1st day, 11th day, 21st day, 31st day
Moderate improvement: 51-75%
时间窗: 1st day, 11th day, 21st day, 31st day
Marked improvement: 76-99%
时间窗: 1st day, 11th day, 21st day, 31st day
Complete remission: 100%
时间窗: 1st day, 11th day, 21st day, 31st day
次要结局
- Assessment of sign and symptoms(after one month of completion of therapy)
研究者
Dr Krishna Kumar Sharma
Rishikul Campus UAU, Haridwar
